Filer Snapshot

David Leslie Szekeres

CIK 0001602459. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity Type

Individual

Total Filings

25

Latest Filing

16 Mar 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for CNTB. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

3 filed on 16 Mar 2026 for CIK 0001602459.

View Source Filing
Identity
Business address
C/O Regulus Therapeutics Inc., 3545 John Hopkins Court, Suite 210, San Diego, CA, 92121
SEC ownership signals
Filing-backed coverage

Insider holdings value

$730.1K

Parsed Forms 3/4/5 holdings where value can be estimated.

Filer intelligence

What SEC filings say about David Leslie Szekeres

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Forms 3/4/5 show insider context for CNTB worth $571.7K.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 3 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

CNTB

16 Mar 2026 · President

$571.7K

HRTX

13 Jul 2023 · EVP, Chief Operating Officer

$122.8K

GRI

18 Sep 2025

$35.6K

Latest update

What changed recently for David Leslie Szekeres

Ownership report updated

Latest ownership report period: 16 Mar 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

16 Mar 2026

Page type

Ownership filings

Latest period

16 Mar 2026

Ownership context was refreshed from SEC Forms 3/4/5 filed on 16 Mar 2026.

SEC filing record

CIK 0001602459 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
25
First seen
13 Mar 2014
Latest filing
16 Mar 2026
Entity
Individual

Latest Filings

Showing the latest 12 of 25 SEC filings for David Leslie Szekeres.

3 File 001-40212

FORM 3

Filing date
16 Mar 2026
Reporting date
16 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40034

FORM 4

Filing date
22 Sep 2025
Reporting date
18 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40034

FORM 4

Filing date
27 Aug 2025
Reporting date
26 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40034

FORM 4

Filing date
14 Aug 2025
Reporting date
13 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40034

FORM 4

Filing date
24 Jan 2025
Reporting date
23 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40034

FORM 4

Filing date
14 Aug 2023
Reporting date
10 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-33221

FORM 4 SUBMISSION

Filing date
17 Jul 2023
Reporting date
13 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-40034

FORM 3

Filing date
24 Apr 2023
Reporting date
21 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-33221

FORM 4 SUBMISSION

Filing date
17 Apr 2023
Reporting date
13 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-33221

FORM 4 SUBMISSION

Filing date
20 Jan 2023
Reporting date
18 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-33221

FORM 4 SUBMISSION

Filing date
17 Jan 2023
Reporting date
13 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-33221

FORM 4 SUBMISSION

Filing date
17 Oct 2022
Reporting date
13 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .